# A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication

> **NCT01131013** · PHASE2 · COMPLETED · sponsor: **Cytokinetics** · enrollment: 61 (actual)

## Conditions studied

- Intermittent Claudication
- Peripheral Artery Disease

## Interventions

- **DRUG:** Placebo
- **DRUG:** 375 mg CK-2017357
- **DRUG:** 500 mg CK-2017357

## Key facts

- **NCT ID:** NCT01131013
- **Lead sponsor:** Cytokinetics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2019-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01131013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01131013, "A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01131013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*